Hap Trading, LLC Karyopharm Therapeutics Inc. Call Options Transaction History

Hap Trading, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$2.48 - $5.93 $1,984 - $4,744	800 Added 5.67%	14,900 $0
Q3 2022 Nov 14, 2022	SELL	$4.08 - $5.82 $28,560 - $40,740	-7,000 Reduced 33.18%	14,100 $4,000
Q2 2022 Aug 12, 2022	BUY	$4.15 - $8.37 $15,770 - $31,805	3,800 Added 21.97%	21,100 $4,000
Q1 2022 May 12, 2022	BUY	$5.91 - $14.38 $14,184 - $34,512	2,400 Added 16.11%	17,300 $10,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $8.61 $77,629 - $128,288	14,900 New	14,900 $10,000
Q1 2021 May 14, 2021	SELL	$9.85 - $17.69 $182,225 - $327,265	-18,500 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$14.15 - $17.19 $101,880 - $123,768	7,200 Added 63.72%	18,500 $11,000
Q3 2020 Nov 13, 2020	SELL	$14.14 - $19.71 $180,992 - $252,288	-12,800 Reduced 53.11%	11,300 $9,000
Q2 2020 Aug 10, 2020	BUY	$16.6 - $25.25 $46,480 - $70,700	2,800 Added 13.15%	24,100 $16,000
Q2 2019 Aug 14, 2019	SELL	$4.32 - $6.43 $56,160 - $83,590	-13,000 Reduced 37.9%	21,300 $30,000
Q1 2019 May 10, 2019	BUY	$4.12 - $10.25 $141,316 - $351,575	34,300 New	34,300 $26,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $54.3M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.